Abstract:In our previous study, osteopontin (OPN) was identified as one of the leading genes that promote the metastasis of hepatocellular carcinoma (HCC). However, the mechanism by which OPN promotes metastasis of HCC is not understood. In this study, RNA interference mediated by viral vectors-which could induce a long-lasting down-regulation in gene expression-was applied to analyze the role of OPN in metastasis of HCC. Three lentiviral vectors encoding microRNA against OPN, Lenti.OPNi-1, Lenti.OPNi-2, and Lenti.OPNi-3, were constructed and found to down-regulate the OPN level by 62%,78%, and 95%, respectively, in HCCLM3 cells which had an overexpression of OPN and a higher metastatic potential. Consequently, both Lenti.OPNi-2 and Lenti.OPNi-3 induced a significant decrease in matrix metalloproteinase (MMP)-2 and urokinase plasminogen activator expression, and led to an obvious inhibition of both in vitro invasion and in vivo lung metastasis of HCCLM3 cells (P < 0.001). Moreover, Lenti.OPNi-3, rather than Lenti.OPNi-2, could also suppress in vitro proliferation and in vivo tumor growth of HCCLM3. Smaller detectable tumors were found in only 50% of mice after implantation of Lenti.OPNi-3-transfected HCCLM3 cells (341 +/- 502.6 mm(3) versus > 3500 mm(3) in controls; P < 0.001). Lenti.OPNi-3, not Lenti.OPNi-2, significantly suppressed the MEK/ERKI/2 pathway in HCCLM3 cells. Recombinant OPN was found to induce translocation of p65 into the nucleus of HCC cells and activation of MMP-2 and MEK/ERK/1/2, which were suppressed by the nuclear factor kappa B (NF-kappa B) inhibitor pyrrolidine dithiocarbamate. Conclusion: OPN plays an important role in metastasis as well as tumor growth of HCC, in which different minimum threshold levels of OPN are needed. These effects may occur through activation of the mitogen-activated protein kinase and NF-kappa B pathways, and MMP-2. OPN could be a hopeful target for the control of HCC. (HEPATOLOGY 2008;48:1834-1842.)

Spatial Localization of the JAG1/Notch1/osteopontin Cascade Modulates Extrahepatic Metastasis in Hepatocellular Carcinoma

Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.

C-C Chemokine Receptor Type 1 Mediates Osteopontin-Promoted Metastasis in Hepatocellular Carcinoma

Transmembrane Receptor CXCR7 Increases the Risk of Extrahepatic Metastasis of Relatively Well-Differentiated Hepatocellular Carcinoma Through Upregulation of Osteopontin.

Metastasis-related genes regulated by osteopontin in human hepatocellular carcinoma cell line SMMC-7721

Relative Analysis of OPN and Its Related Signal Molecules in Hepatocellular Carcinoma

High-resolution Analysis of Genomic Profiles of Hepatocellular Carcinoma Cells with Differential Osteopontin Expression

Osteopontin Promotes Hepatocellular Carcinoma Invasion by Up-Regulating MMP-2 and Upa Expression.

Transcriptional Regulation of Human Osteopontin in Hepatocellular Cacinoma Cells

Lentiviral-mediated Mirna Against Osteopontin Suppresses Tumor Growth and Metastasis of Human Hepatocellular Carcinoma

Overexpression of Osteopontin in Hepatocellular Carcinoma and Its Relationships with Metastasis, Invasion of Tumor Cells

Osteopontin is A Promoter for Hepatocellular Carcinoma Metastasis: A Summary of 10 Years of Studies

Prognostic Significance of Hes-1, a Downstream Target of Notch Signaling in Hepatocellular Carcinoma.

Down-regulation of Osteopontin Inhibits Metastasis of Hepatocellular Carcinoma Cells Via a Mechanism Involving MMP-2 and Upa.

Osteopontin Promotes Metastasis of Intrahepatic Cholangiocarcinoma Through Recruiting MAPK1 and Mediating Ser675 Phosphorylation of Β-Catenin

Combination of Osteopontin with Peritumoral Infiltrating Macrophages is Associated with Poor Prognosis of Early-Stage Hepatocellular Carcinoma after Curative Resection

Role of Hepatocyte‐Derived Osteopontin in Liver Carcinogenesis

Osteopontin, a Single Marker for Predicting the Prognosis of Patients with Tumor‐node‐metastasis Stage I Hepatocellular Carcinoma after Surgical Resection

Osteopontin Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Through Regulating Vimentin.

Abstract 2695: Osteopontin Regulated Epithelial-Mesenchymal Transition Via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma.

Transcription Factor C-Myb Promotes the Invasion of Hepatocellular Carcinoma Cells Via Increasing Osteopontin Expression